Profile
AMYT ZTS TAK HLN TEVA ITCI
Company Name Amryt Pharma plc Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap - $67.47B $45.57B $44.51B $18.42B $14.05B
Employees 0.29K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Joseph A. Wiley Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Sharon Mates
Ratings
AMYT ZTS TAK HLN TEVA ITCI
Quant Rating Score 3 3 3 3 2 1
Quant Rating Neutral Neutral Neutral Neutral Sell Strong Sell
Trading
AMYT ZTS TAK HLN TEVA ITCI
Last Close $14.7 $148.6 $14.43 $9.6 $16.06 $131.87
High 52 $14.7 $196.48 $15.46 $11.41 $22.77 $131.91
Low 52 $14.7 $144.45 $12.89 $8.84 $12.82 $71.19
Price vs. 52 Week High 0 % -24.37 % -6.66 % -15.86 % -29.47 % -0.03 %
Price vs. 52 Week Low 0 % 2.87 % 11.95 % 8.6 % 25.27 % 85.24 %
Total Return
AMYT ZTS TAK HLN TEVA ITCI
1 Month Return 0 % -5.45 % -2.3 % -7.78 % -5.25 % 0 %
3 Month Return 0 % -0.05 % -1.9 % -6.07 % 17.66 % 0 %
6 Month Return 0 % -10.42 % 11.69 % 3.9 % -26.73 % 4.49 %
9 Month Return 0 % -23.12 % 0.7 % -4.86 % -10.53 % 68.33 %
YTD Return 0 % -8.8 % 8.99 % 0.63 % -27.13 % 57.89 %
1 Year Return 0 % -16.79 % 8.01 % 7.74 % -4.46 % 76.16 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AMYT ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.23 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) 10.05 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Profitability
AMYT ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 52.32 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -2.32 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM -9 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM -3.46 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 60.95 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 137.75 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -9.72 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM 7.8 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 4.13 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 2.58 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 0.92 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 3000.85 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 28.41 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM 0.33 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM 0.3 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 239.07 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM 6.98 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 90.05 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM 7.8 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM - 29.58 9.74 - 24.3 -191.12
Price To Operating Cash Flows Ratio TTM 44.65 23.03 7.13 - 14.57 -185.85
Price Cash Flow Ratio TTM 44.65 23.03 7.13 - 14.57 -185.85
Income Statement (TTM)
AMYT ZTS TAK HLN TEVA ITCI
Revenue $0.22B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.12B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 52.32% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $0.03B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.02B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -0.37 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
AMYT ZTS TAK HLN TEVA ITCI
Long Term Debt $0.2B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.45B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0.34B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.2B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.78B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
AMYT ZTS TAK HLN TEVA ITCI
Net Income $-0.02B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0.01B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $0.02B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.53
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.21
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.63
ALVOW Alvotech 1.65
AMPH Amphastar Pharmaceuticals, Inc. 20.62
AMRX Amneal Pharmaceuticals, Inc. 7.97
ANIP ANI Pharmaceuticals, Inc. 66.3
APUS Apimeds Pharmaceuticals US, Inc 1.77
AQST Aquestive Therapeutics, Inc. 4.2
ASRT Assertio Holdings, Inc. 0.673
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 10.83
AYTU Aytu BioPharma, Inc. 2.37
ETFs With Exposure to AMYT
Ticker ETF Name Weight Percentage Price
GWX SPDR S&P International Small Cap ETF 0.04 37.41
Unlock